Medtronic (NYSE: MDT) announced that it received FDA approval for its OmniaSecure defibrillation lead for right ventricle ...

Johnson & Johnson MedTech announced positive three-month results from a study evaluating its investigational Omnypulse ...

A new study sheds new light on these big questions, illuminating a general principle of neural processing in a mysterious region of the midbrain that is the very origin of our central serotonin (5-HT) ...

Serotonin neurons in the brainstem are not independent, as once thought, but interact to influence decision-making.

Integer Holdings Corporation ITGR delivered adjusted earnings per share (EPS) of $1.31 in the first quarter of 2025, which ...

Boston Scientific’s FARAPULSE system is showing some serious promise in zapping away persistent atrial fibrillation, ...

With careful consideration of several factors, many patients can avoid an overnight stay, reducing costs without sacrificing ...

Q1 2025 earnings highlight 7% sales growth, enhanced margins, raised EPS guidance, and strategic acquisitions for sustained ...

Led by Farapulse founder Steven Mickelsen, Field has developed a pulsed field ablation device to tackle the dangerous heart ...

Symposium will also feature presentation on the BACKBEAT global pivotal study Orchestra BioMed is currently enrolling in strategic collaboration with Medtronic, plc (NYSE: MDT) ...

Belmont Bay Rehabilitation & Healthcare Center in Woodbridge has launched a cardiac care program under the direction of ...